ArticleMedical archives (Sarajevo, Bosnia and Herzegovina)2022
Laboratory Diagnosis, Antimicrobial Susceptibility And Genuine Clinical Spectrum of
Article in Medical archives (Sarajevo, Bosnia and Herzegovina), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- From commensal to pathogen: recent advances in the pathogenicity and clinical implications ofFrontiers in microbiology · 2026Review
- Article
- Review
- Beyond the usual suspects: emerging uropathogens in the microbiome age.Frontiers in urology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Objectives: The aim of this study is to suggest a reasonable identification approach that is suitable for laboratories of limited resources, to detect any possible emerging antimicrobial resistance, and to assess the genuine clinical spectrum of infections that are caused solely by SAG. Methods: Our research included 190 bacterial isolates from 190 patients. The isolates were examined by colonies' morphology, odor, hemolytic pattern on 5% sheep Blood agar and Gram staining. Lancefield serogrouping was determined by agglutination test. Antimicrobial susceptibility testing (AST) was performed by disc diffusion method. The isolates were subjected to automated identification and AST by Vitek 2 compact instrument. The collected patients' data included age, gender, clinical condition and/or site of infection, and probable predisposing factor. Results: All isolates produced minute-sized colonies that consistently generated distinct odor. The isolates showed variable hemolytic patterns, and the majority (74.7%) were non-hemolytic. The isolates showed different Lancefield serogroups, and the commonest was group F (54.2%). A total of 188 (98.9%) isolates were identified by Vitek 2 compact instrument at ≥95% confidence. The isolates showed high rates of antimicrobial susceptibility, however the highest rate of antimicrobial resistance was detected to gentamicin (60.5%). A total of 98 (51.6%) strains were isolated from superficial non-invasive skin and soft tissue infections, 67 (35.3%) strains from deep invasive and sterile body fluids' infections, and 25 (13.1%) strains from upper respiratory tracts' infections. Conclusion: a combination of phenotypic characteristics could still represent a reasonable Laboratory identification battery. There was no significant emerging antimicrobial resistance detected. A broad genuine spectrum of clinical infections that are caused solely by SAG was reported in our institution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.